BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 227 filers reported holding BEAM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,515,734 | -29.8% | 64,692 | -1.0% | 0.00% | – |
| Q1 2024 | $2,159,791 | +64.8% | 65,369 | +35.7% | 0.00% | – |
| Q4 2023 | $1,310,943 | +9.0% | 48,161 | -3.7% | 0.00% | – |
| Q3 2023 | $1,203,246 | -25.2% | 50,031 | -0.7% | 0.00% | – |
| Q2 2023 | $1,608,473 | +3.7% | 50,375 | -0.6% | 0.00% | – |
| Q1 2023 | $1,551,117 | +20.3% | 50,657 | +53.6% | 0.00% | – |
| Q4 2022 | $1,289,496 | -5.8% | 32,971 | +14.7% | 0.00% | – |
| Q3 2022 | $1,369,000 | +39.7% | 28,752 | +13.6% | 0.00% | – |
| Q2 2022 | $980,000 | -23.3% | 25,311 | +13.5% | 0.00% | – |
| Q1 2022 | $1,278,000 | -27.2% | 22,307 | +1.3% | 0.00% | – |
| Q4 2021 | $1,756,000 | -13.5% | 22,030 | -5.6% | 0.00% | -100.0% |
| Q3 2021 | $2,030,000 | -17.3% | 23,335 | +22.3% | 0.00% | 0.0% |
| Q2 2021 | $2,456,000 | +200.2% | 19,082 | +86.7% | 0.00% | – |
| Q1 2021 | $818,000 | -94.5% | 10,218 | -94.4% | 0.00% | -100.0% |
| Q4 2020 | $14,909,000 | – | 182,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $74,937,603 | 45.33% |
| HSG Holding Ltd | 796,089 | $25,419,122 | 2.91% |
| Deep Track Capital, LP | 1,317,316 | $42,061,900 | 1.95% |
| Redmile Group, LLC | 1,485,199 | $47,422,404 | 1.82% |
| ARK Investment Management | 8,382,595 | $267,656,246 | 1.77% |
| Casdin Capital, LLC | 570,000 | $18,200,100 | 1.59% |
| Yiheng Capital Management, L.P. | 463,800 | $14,809,134 | 0.80% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $137,867,003 | 0.80% |
| Alphabet Inc. | 321,604 | $10,268,815 | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,441,522 | $109,887,797 | 0.55% |